The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis
A Galvano, L Castellana, V Gristina… - Therapeutic …, 2022 - journals.sagepub.com
Background: The circulating tumor DNA (ctDNA) diagnostic accuracy for detecting
phosphatidylinositol 4, 5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutations …
phosphatidylinositol 4, 5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutations …
Molecular tumor board
M La Mantia, G Busuito, V Spinnato, V Gristina… - Liquid Biopsy, 2023 - Elsevier
The new multidisciplinary approach, called “Molecular Tumor board”, arises from a
collaboration of specialists and subspecialists, from a variety of fields, who meet to review …
collaboration of specialists and subspecialists, from a variety of fields, who meet to review …
Early detection screening: myth or reality?
M La Mantia, F Iacono, S Cutaia, V Gristina, A Perez… - Liquid Biopsy, 2023 - Elsevier
Historically, surgical biopsy has been considered the gold standard for cancer diagnosis.
Nonetheless, surgical biopsies are not always feasible, and the procedures are often …
Nonetheless, surgical biopsies are not always feasible, and the procedures are often …
The role of mutated ctDNA in nonmalignant lesions: challenging aspects in liquid biopsy implementation
V Gristina, U Malapelle, P Pisapia… - Liquid Biopsy: New …, 2022 - books.google.com
By the end of the chapter the reader will:• have learned the basic concepts of clinical
employment of liquid biopsy;• have deep knowledges on circulating tumor cells, circulating …
employment of liquid biopsy;• have deep knowledges on circulating tumor cells, circulating …